Berry Consultants Revenue and Competitors

Claim your profile

Austin, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Berry Consultants's estimated annual revenue is currently $3.9M per year.(i)
  • Berry Consultants's estimated revenue per employee is $83,394

Employee Data

  • Berry Consultants has 47 Employees.(i)
  • Berry Consultants grew their employee count by 31% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.1M11020%N/AN/A
#2
$5.4M6523%N/AN/A
#3
$62.5M0N/AN/AN/A
#4
$3.9M4731%N/AN/A
#5
$3.2M170%$48.2MN/A
#6
$78.4M39019%N/AN/A
#7
$19.5M9759%N/AN/A
#8
$75.2M3741%N/AN/A
#9
$4.4M53-2%N/AN/A
#10
$5.8M2916%N/AN/A

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, analysis, execution, and software solutions for the pharmaceutical and medical device industry. Berry Consultants’ primary services include designing adaptive clinical trials, conducting comparative effectiveness research such as decision analysis and meta-analysis, providing strategic operational excellence and knowledge of advanced trial implementation, supporting interim analysis and trial updates during the execution of adaptive trials, participating on Data Monitoring Committees, and licensing FACTS (Fixed and Adaptive Clinical Trial Simulator) software which is the most powerful, flexible, and fastest simulation tool on the market for advanced clinical trial design. The Berry Consultants team has extensive experience in working with clinical investigators, scientific domain experts, FDA, and EMA in the design, simulation, and implementation of complex adaptive clinical trials that range from proof of concept studies to some of the most innovative multi-drug platform trials.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$3.9M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M47-24%N/A
#2
$10.9M47N/AN/A
#3
$8.3M47N/AN/A
#4
$9.4M4712%N/A
#5
$10.2M477%N/A